can glp 1 cause joint pain GLP-1 and Inflammation: What You Need to Know GLP-1 drugs calm inflammation beyond

What Prescribers Should Do Right Now Communicate proactively with patients on estrogen patches

The move, announced Tuesday morning, comes after weight loss rival Eli Lilly overtook the Danish pharma in GLP-1 sales in 2025 and just a day after Novos market cap sunk to pre-Wegovy levels following a clinical loss of next-gen obesity candidate CagriSema to Lillys Zepbound

Despite the development of next-generation analogs with improved pharmacological properties, clinical translation is constrained by a narrow therapeutic window due to on-target and off-target toxicities

ng lo lng, bn c th ung b li ngay sau khi nh ra